View on Pubmed.gov 10052405 | View on doi.org 10.1001/archder...
Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial.
- Department of Dermatology, University Hospital Charité, Berlin Humboldt University, Germany.
Abstract
OBJECTIVE
To determine the safety and clinical effects of interleukin 10 (IL-10) treatment of psoriasis.
DESIGN AND METHODS
In an open-label phase 2 trial, 10 patients with psoriasis subcutaneously received recombinant human IL-10 over a 7-week period in a dosage of 8 microg/kg daily (n=5) or 20 microg/kg 3 times per week (n=5). Patients were followed up for an additional 5 weeks.
RESULTS
The treatment was well tolerated. Antipsoriatic effects were found in all but 1 patient. A significant decrease of the psoriasis area and severity index by 55.3% +/- 11.5% (mean +/- SEM) was observed (P<.02). The antipsoriatic efficiency was confirmed by histological examination. Heterogeneity in the effectiveness was found among the patients, but seems to be independent of the dosage regimen. However, a tendency to a better response was found in the patients who received 20-microg/kg IL-10 3 times per week. Decreasing response in the delayed-type hypersensitivity reaction against recall antigens indicated immunosuppressive effects. Moderate effects on hematopoietic cells were observed.
CONCLUSIONS
Our data suggest that IL-10 therapy for psoriasis is safe and possibly clinically effective. Consequently, its value in psoriasis and similar immune diseases should be further determined. Dose-finding, placebo-controlled, double-blind trials are necessary now.
References
Cited by 155 citations (total)
Journal Article Review
The immunologic effects of estrogen on psoriasis: A comprehensive review.
Electronic publication date May 14, 2015
Melissa Danesh [...] Jenny E Murase et al.
BACKGROUND
Immunological changes in pregnancy are associated with improvements in some pre-existing immune-mediated skin diseases. Estrogen has been hypothesized to contribute...
Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection.
Electronic publication date November 26, 2002
Sanbao Ruan [...] Judd E Shellito et al.
The relationship between tissue inflammation and clearance of the opportunistic pathogen Pneumocystis carinii is poorly understood. We asked whether the...